IBDEI1QT ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29575,1,4,0)
 ;;=4^A54.00
 ;;^UTILITY(U,$J,358.3,29575,2)
 ;;=^5000311
 ;;^UTILITY(U,$J,358.3,29576,0)
 ;;=Z11.3^^115^1473^14
 ;;^UTILITY(U,$J,358.3,29576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29576,1,3,0)
 ;;=3^Screen,Gonorrhea
 ;;^UTILITY(U,$J,358.3,29576,1,4,0)
 ;;=4^Z11.3
 ;;^UTILITY(U,$J,358.3,29576,2)
 ;;=^5062672
 ;;^UTILITY(U,$J,358.3,29577,0)
 ;;=A60.04^^115^1473^8
 ;;^UTILITY(U,$J,358.3,29577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29577,1,3,0)
 ;;=3^Herpesviral Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,29577,1,4,0)
 ;;=4^A60.04
 ;;^UTILITY(U,$J,358.3,29577,2)
 ;;=^5000356
 ;;^UTILITY(U,$J,358.3,29578,0)
 ;;=N89.8^^115^1473^9
 ;;^UTILITY(U,$J,358.3,29578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29578,1,3,0)
 ;;=3^Leukorrhea
 ;;^UTILITY(U,$J,358.3,29578,1,4,0)
 ;;=4^N89.8
 ;;^UTILITY(U,$J,358.3,29578,2)
 ;;=^88111
 ;;^UTILITY(U,$J,358.3,29579,0)
 ;;=N73.0^^115^1473^10
 ;;^UTILITY(U,$J,358.3,29579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29579,1,3,0)
 ;;=3^Pelvic Cellulitis
 ;;^UTILITY(U,$J,358.3,29579,1,4,0)
 ;;=4^N73.0
 ;;^UTILITY(U,$J,358.3,29579,2)
 ;;=^270467
 ;;^UTILITY(U,$J,358.3,29580,0)
 ;;=T81.4XXD^^115^1473^11
 ;;^UTILITY(U,$J,358.3,29580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29580,1,3,0)
 ;;=3^Post-op Wound Infection,Subs Encntr
 ;;^UTILITY(U,$J,358.3,29580,1,4,0)
 ;;=4^T81.4XXD
 ;;^UTILITY(U,$J,358.3,29580,2)
 ;;=^5054480
 ;;^UTILITY(U,$J,358.3,29581,0)
 ;;=N76.1^^115^1473^17
 ;;^UTILITY(U,$J,358.3,29581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29581,1,3,0)
 ;;=3^Vaginitis,Subacute and Chronic
 ;;^UTILITY(U,$J,358.3,29581,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,29581,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,29582,0)
 ;;=A53.9^^115^1473^15
 ;;^UTILITY(U,$J,358.3,29582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29582,1,3,0)
 ;;=3^Syphilis
 ;;^UTILITY(U,$J,358.3,29582,1,4,0)
 ;;=4^A53.9
 ;;^UTILITY(U,$J,358.3,29582,2)
 ;;=^5000310
 ;;^UTILITY(U,$J,358.3,29583,0)
 ;;=A59.01^^115^1473^16
 ;;^UTILITY(U,$J,358.3,29583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29583,1,3,0)
 ;;=3^Trichomonal Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,29583,1,4,0)
 ;;=4^A59.01
 ;;^UTILITY(U,$J,358.3,29583,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,29584,0)
 ;;=A64.^^115^1473^18
 ;;^UTILITY(U,$J,358.3,29584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29584,1,3,0)
 ;;=3^Venereal Disease
 ;;^UTILITY(U,$J,358.3,29584,1,4,0)
 ;;=4^A64.
 ;;^UTILITY(U,$J,358.3,29584,2)
 ;;=^5000362
 ;;^UTILITY(U,$J,358.3,29585,0)
 ;;=L81.8^^115^1474^1
 ;;^UTILITY(U,$J,358.3,29585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29585,1,3,0)
 ;;=3^Abnormal Skin Pigment
 ;;^UTILITY(U,$J,358.3,29585,1,4,0)
 ;;=4^L81.8
 ;;^UTILITY(U,$J,358.3,29585,2)
 ;;=^5009318
 ;;^UTILITY(U,$J,358.3,29586,0)
 ;;=L70.0^^115^1474^2
 ;;^UTILITY(U,$J,358.3,29586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29586,1,3,0)
 ;;=3^Acne Vulgaris
 ;;^UTILITY(U,$J,358.3,29586,1,4,0)
 ;;=4^L70.0
 ;;^UTILITY(U,$J,358.3,29586,2)
 ;;=^5009268
 ;;^UTILITY(U,$J,358.3,29587,0)
 ;;=L65.9^^115^1474^3
 ;;^UTILITY(U,$J,358.3,29587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29587,1,3,0)
 ;;=3^Alopecia
 ;;^UTILITY(U,$J,358.3,29587,1,4,0)
 ;;=4^L65.9
 ;;^UTILITY(U,$J,358.3,29587,2)
 ;;=^5009252
 ;;^UTILITY(U,$J,358.3,29588,0)
 ;;=L20.89^^115^1474^4
 ;;^UTILITY(U,$J,358.3,29588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29588,1,3,0)
 ;;=3^Atopic Dermatitis
 ;;^UTILITY(U,$J,358.3,29588,1,4,0)
 ;;=4^L20.89
 ;;^UTILITY(U,$J,358.3,29588,2)
 ;;=^5009112
 ;;^UTILITY(U,$J,358.3,29589,0)
 ;;=D23.9^^115^1474^5
 ;;^UTILITY(U,$J,358.3,29589,1,0)
 ;;=^358.31IA^4^2
